These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34199734)

  • 1. Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study.
    Saussez S; Vaira LA; Chiesa-Estomba CM; Bon SL; Horoi M; Deiana G; Petrocelli M; Boelpaep P; Salzano G; Khalife M; Hans S; De Riu G; Hopkins C; Lechien JR
    Pathogens; 2021 Jun; 10(6):. PubMed ID: 34199734
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: a prospective study.
    Lechien JR; Vaira LA; Saussez S
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1255-1263. PubMed ID: 36153785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients.
    Lechien JR; Chiesa-Estomba CM; Vaira LA; De Riu G; Cammaroto G; Chekkoury-Idrissi Y; Circiu M; Distinguin L; Journe F; de Terwangne C; Machayekhi S; Barillari MR; Calvo-Henriquez C; Hans S; Saussez S
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):2851-2859. PubMed ID: 33452919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.
    Le Bon SD; Konopnicki D; Pisarski N; Prunier L; Lechien JR; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3113-3117. PubMed ID: 33423106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics.
    Cantone E; D'Ascanio L; De Luca P; Roccamatisi D; La La Mantia I; Brenner MJ; Di Stadio A
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3671-3678. PubMed ID: 38492007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter real-life study to determine the efficacy of corticosteroids and olfactory training in improving persistent COVID-19-related olfactory dysfunction.
    Pendolino AL; Ottaviano G; Nijim J; Scarpa B; De Lucia G; Berro C; Nicolai P; Andrews PJ
    Laryngoscope Investig Otolaryngol; 2022 Dec; 8(1):46-54. PubMed ID: 36718474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients.
    Vaira LA; Lechien JR; Khalife M; Petrocelli M; Hans S; Distinguin L; Salzano G; Cucurullo M; Doneddu P; Salzano FA; Biglioli F; Journe F; Piana AF; De Riu G; Saussez S
    Pathogens; 2021 Jan; 10(1):. PubMed ID: 33445604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction.
    Lechien JR; Le Bon SD; Saussez S
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2351-2358. PubMed ID: 36520209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction.
    Saussez S; Sharma S; Thiriard A; Olislagers V; Vu Duc I; Le Bon SD; Khalife M; Hans S; De Riu G; Hopkins C; Lechien JR; Vaira LA; Marchant A
    Eur J Neurol; 2021 Nov; 28(11):3702-3711. PubMed ID: 34157187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients.
    Lechien JR; Chiesa-Estomba CM; Beckers E; Mustin V; Ducarme M; Journe F; Marchant A; Jouffe L; Barillari MR; Cammaroto G; Circiu MP; Hans S; Saussez S
    J Intern Med; 2021 Aug; 290(2):451-461. PubMed ID: 33403772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of prevalence and evolution of COVID-19 olfactory disorders in patients infected by D614 (wild) and B.1.1.7. Alpha variant: a brief report.
    Lechien JR; Wajsblat S; Horoi M; Boscolo-Rizzo P; Le Bon SD; Vaira LA; Saussez S
    Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3461-3467. PubMed ID: 36943439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory Cleft Measurements and COVID-19-Related Anosmia.
    Altundag A; Yıldırım D; Tekcan Sanli DE; Cayonu M; Kandemirli SG; Sanli AN; Arici Duz O; Saatci O
    Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1337-1344. PubMed ID: 33045908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Olfactory MRI, DTI and fMRI Study of COVID-19 Related Anosmia and Post Viral Olfactory Dysfunction.
    Yildirim D; Kandemirli SG; Tekcan Sanli DE; Akinci O; Altundag A
    Acad Radiol; 2022 Jan; 29(1):31-41. PubMed ID: 34810059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory training in long COVID-19 patients with lasting symptoms including olfactory dysfunction.
    Fjaeldstad AW; Ovesen T; Stankevice D; Ovesen T
    Dan Med J; 2023 Feb; 70(3):. PubMed ID: 36896723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pilot Study of Short-Course Oral Vitamin A and Aerosolised Diffuser Olfactory Training for the Treatment of Smell Loss in Long COVID.
    Chung TW; Zhang H; Wong FK; Sridhar S; Lee TM; Leung GK; Chan KH; Lau KK; Tam AR; Ho DT; Cheng VC; Yuen KY; Hung IF; Mak HK
    Brain Sci; 2023 Jun; 13(7):. PubMed ID: 37508945
    [No Abstract]   [Full Text] [Related]  

  • 16. Olfactory dysfunction and training in children with COVID-19 infection: A prospective study Post-COVID pediatric olfactory training.
    Chan KH; Thomas BJ; Gilbert DD; Tong S; Teynor NJ; Friedman NR; Herrmann BW; Gitomer SA
    Int J Pediatr Otorhinolaryngol; 2024 Jan; 176():111799. PubMed ID: 38081110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parosmia COVID-19 Related Treated by a Combination of Olfactory Training and Ultramicronized PEA-LUT: A Prospective Randomized Controlled Trial.
    Di Stadio A; Cantone E; De Luca P; Di Nola C; Massimilla EA; Motta G; La Mantia I; Motta G
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of olfactory dysfunction and parosmia in mild COVID-19 cases.
    Monk AS; Bacon DR; Onuorah P; Murr A; Wiesen CA; Oakes J; Thorp BD; Ebert CS; Wohl D; Senior BA; Kimple AJ
    Rhinol Online; 2022; 5():168-172. PubMed ID: 37008801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sniffin'Sticks: a new olfactory test battery.
    Wolfensberger M; Schnieper I; Welge-Lüssen A
    Acta Otolaryngol; 2000 Mar; 120(2):303-6. PubMed ID: 11603794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory Training Impacts Olfactory Dysfunction Induced by COVID-19: A Pilot Study.
    Bérubé S; Demers C; Bussière N; Cloutier F; Pek V; Chen A; Bolduc-Bégin J; Frasnelli J
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):57-66. PubMed ID: 36529118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.